Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symptoms and Physical Activity in COPD Patients in Europe

NCT03031769 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03031769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03031769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symptoms and Physical Activity in COPD Patients in Europe
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 21, 2016
Completion date
August 31, 2017
Enrollment
2,176 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd